Korro Bio Q3 EPS $(0.98) Beats $(1.26) Estimate

Benzinga · 1d ago
Korro Bio (NASDAQ:KRRO) reported quarterly losses of $(0.98) per share which beat the analyst consensus estimate of $(1.26) by 22.22 percent. This is a 48.96 percent increase over losses of $(1.92) per share from the same period last year.